Frontlight ResearchEarly access
Trial site
CardioMed S.R.L.
- 10running trials
- 9closed trials
The trials here
What the 20 trials at this site are about, from their registry records.
- Conditions
- Lung cancer13 trials
- Head and neck cancer2 trials
- Bladder cancer1 trial
- Chronic rhinosinusitis with nasal polyps1 trial
- Colorectal cancer1 trial
- Kidney cancer1 trial
- Metastatic breast cancer1 trial
- Phase
- Phase 315 trials
- Phase 23 trials
- Phase 2/32 trials
- Status
- Completed9 trials
- Recruiting6 trials
- Active, not recruiting4 trials
- Suspended1 trial
- Lead sponsor
- Merck Sharp & Dohme LLC11 trials
- BioNTech SE2 trials
- Regeneron Pharmaceuticals2 trials
- AbbVie1 trial
- Bayer1 trial
- and 3 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer4 recruiting
- Chronic rhinosinusitis with nasal polyps1 recruiting
- Head and neck cancer1 recruiting
Closed trials
Active, not recruiting
Active, not recruiting
Completed
Completed
Active, not recruiting
Completed
A study of MK7684A versus Pembrolizumab in PD-L1 Positive Metastatic NSCLC (KEYVIBE-003)
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026